MBB Public Markets’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-307
Closed -$239K 296
2025
Q2
$239K Sell
307
-69
-18% -$53.6K 0.02% 416
2025
Q1
$311K Buy
+376
New +$313K 0.03% 344
2024
Q4
Sell
-360
Closed -$319K 353
2024
Q3
$319K Sell
360
-57,105
-99% -$51.3M 0.02% 370
2024
Q2
$52M Buy
57,465
+55,955
+3,706% +$44.8M 1.05% 16
2024
Q1
$1.17M Buy
+1,510
New +$1.07M 0.07% 89
2022
Q1
Sell
-5,263
Closed -$1.45M 283
2021
Q4
$1.45M Buy
+5,263
New +$1.33M 0.03% 95

Other funds holding LLY

MBB Public Markets's LLY Position: Q3 2025 in Review

MBB Public Markets sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 307 shares — an estimated $239K sold.

MBB Public Markets first reported a position in LLY in Q4 2021 and held it in 6 quarters. The position peaked at $52M in Q2 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • MBB Public Markets reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • MBB Public Markets sold 307 Eli Lilly shares in Q3 2025, an estimated $239K.
  • MBB Public Markets first reported a position in Eli Lilly in Q4 2021 and held it in 6 quarters.
  • MBB Public Markets's Eli Lilly position peaked at $52M in Q2 2024.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on MBB Public Markets's 13F filing for Q3 2025, filed 14 Nov 2025.